- Product Details
Keywords
- Afatinib
- 99% purity Afatinib (BIBW 2992)
- Afatinib (BIBW 2992) manufacturer
Quick Details
- ProName: Afatinib (BIBW 2992)439081-18-2
- CasNo: 439081-18-2
- Molecular Formula: C21H22Cl2FN5O
- Appearance: white powder
- Application: BIBW2992 (Afatinib, Tomtovok, Tovok) i...
- DeliveryTime: Within7-10 days after receipt of your ...
- PackAge: As customer request
- Port: Qingdao,China
- ProductionCapacity: 100 Kilogram/Week
- Purity: 99%
- Transportation: By Sea/Air/Courier
- LimitNum: 10 Gram
Superiority
Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
Details
Afatinib (BIBW 2992)
CAS: | 439081-18-2 |
MF: | C24H25ClFN5O3 |
MW: | 485.944 |
Appearance: | White powder |
Assay: | 99% |
Boiling point: | 676.9±55.0 °C(Predicted) |
desnity: | 1.380 |
Uses: BIBW2992 (Afatinib, Tomtovok, Tovok) irreversibly inhibits EGFR/HER2 including EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2 with IC50 of 0.5 nM, 0.4 nM, 10 nM and 14 nM, respectively. |